Qingjing Zeng
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis 29
-
- MRI in cancer diagnosis 9
- Radiomics and Machine Learning in Medical Imaging 3
-
- Liver Disease Diagnosis and Treatment 17
- Hepatitis B Virus Studies 4
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 13
-
- Gallbladder and Bile Duct Disorders 4
-
- Pancreatic and Hepatic Oncology Research 2
- Co-authors
- Kai LiErjiao XuRongqin ZhengZhongzhen SuLili NiuJie ZengTao WuHairong Zheng
- Partner nations
- ChinaUnited States
In The Last Decade
Qingjing Zeng
29 papers receiving 362 citations
Peers
Comparison fields: 5 of 47
- Hepatology 241
- Radiology, Nuclear Medicine and Imaging 161
- Health Informatics 7
- Epidemiology 138
- Biomedical Engineering 102
Countries citing papers authored by Qingjing Zeng
This map shows the geographic impact of Qingjing Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingjing Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingjing Zeng more than expected).
Fields of papers citing papers by Qingjing Zeng
This network shows the impact of papers produced by Qingjing Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingjing Zeng. The network helps show where Qingjing Zeng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Qingjing Zeng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 0 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 4 | |
| 8 | 2022 | 2 | |
| 9 | 2021 | 3 | |
| 10 | 2021 | 13 | |
| 11 | 2021 | 6 | |
| 12 | 2021 | 9 | |
| 13 | 2021 | 4 | |
| 14 | 2020 | 11 | |
| 15 | 2020 | 2 | |
| 16 | 2019 | 1 | |
| 17 | 2019 | 11 | |
| 18 | 2017 | 43 | |
| 19 | 2013 | 2 | |
| 20 | 2013 | 49 |
About Qingjing Zeng
Qingjing Zeng is a scholar working on Hepatology, Epidemiology and Radiology, Nuclear Medicine and Imaging, having authored 33 papers that have together received 364 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (29 papers), Liver Disease Diagnosis and Treatment (17 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (13 papers), MRI in cancer diagnosis (9 papers), Gallbladder and Bile Duct Disorders (4 papers), Hepatitis B Virus Studies (4 papers), Radiomics and Machine Learning in Medical Imaging (3 papers) and Pancreatic and Hepatic Oncology Research (2 papers). The work is most often cited by research in Hepatology (241 citations), Radiology, Nuclear Medicine and Imaging (161 citations) and Health Informatics (7 citations). Qingjing Zeng has collaborated with scholars based in China and United States. Frequent co-authors include Kai Li, Erjiao Xu, Rongqin Zheng, Zhongzhen Su, Rongqin Zheng, Lili Niu, Jie Zeng, Tao Wu, Hairong Zheng and Congzhi Wang.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.